CAMCEVI ETM FDA approval date
The FDA approved CAMCEVI ETM on 25 Aug 2025.
- FDA approval date
- 25 Aug 2025
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LEUPROLIDE MESYLATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2025-08-25Day | CAMCEVI ETM | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA219745", "applicant_as_listed_by_fda": "ACCORD", "brand_names": ["CAMCEVI ETM"], "active_ingredients": ["LEUPROLIDE MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250825", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |